A Pilot Study to Determine the Effectiveness of Bioelectrical Impedance Analysis as a Clinical Assessment Tool of Nutrition Status in Glioblastoma Multiforme Patients (The BEAM Study [BIA Effectiveness as Assessment Tool for Glioblastoma Multiforme (GBM) Patients])
The purpose of this study is to monitor the nutritional status of (Glioblastoma
Multiforme)GBM patients for one year. We will look at the relationships between phase angle
determined by Bioelectrical Impedance Analysis (BIA), nutrition assessment by Subjective
Global Assessment and serum albumin, the type of microbes present in the gut, the
participant's DNA information, and tumor progression. We will also compare estimated caloric
needs determined by BIA and Harris Benedict Equation to Resting Energy Expenditure from
Indirect Calorimetry of the people with GBM and the people without.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
To evaluate the use of Bioelectrical Impedance Analysis as a clinical assessment tool in Glioblastoma Multiforme patients
The electrical current used by the BIA (Bioelectrical Impedance Analysis) is low and below the level. The electrodes will be placed on hand and foot.
Participants will be followed every 3 months up to 12 months
Louis B Nabors, MD
University of Alabama at Birmingham
United States: Food and Drug Administration
|University of Alabama at Birmingham||Birmingham, Alabama 35294-3300|